Adriann Sax - 23 Jun 2023 Form 4 Insider Report for QSAM Biosciences, Inc.

Role
Director
Signature
/s/ Adriann Sax
Issuer symbol
N/A
Transactions as of
23 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 16:30:47 UTC
Previous filing
07 Mar 2022
Next filing
02 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QSAM Common Stock Award $0 +10,455 $0.000000 10,455 23 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QSAM Options to buy common stock 6,250 23 Jun 2023 Common Stock 6,250 $8.00 Direct F2
holding QSAM Options to buy common stock 18,750 23 Jun 2023 Common Stock 18,750 $10.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met
F2 The option vests annually in two equal installments beginning on 1/25/2023.
F3 The option vests annually in two equal installments beginning on 3/3/2023.